Pulse nav.journalClub Aktive Debatten Trends Entdecken Fragen Forschende

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Start Entdecken nav.journalClub Trends

⌘+K

Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling | Synapse

September 10, 2019Open Access

Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling

Key Points

Key points are not available for this paper at this time.

Abstract

The therapeutic efficacy of anti-TNF in resolving intestinal inflammation is critically dependent on IL-10 signalling in macrophages.

Like

Bookmark

Share

View Full Paper

Like

Bookmark

Share

View Full Paper

Cite This Study

Koelink et al. (Tue,) studied this question.

synapsesocial.com/papers/69d976052a25b240b7a3c5da https://doi.org/https://doi.org/10.1136/gutjnl-2019-318264

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Sixty-year Study of Incidence of Childhood Ulcerative Colitis Finds Eleven-fold Increase Beginning in 1990s2012 · 66 citations
2Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease2017 · 805 citations
3A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis2000 · 1,751 citations
4Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility2008 · 588 citations
5Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management2016 · 713 citations